Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MULTIPLE SCLEROSIS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT02217982
What this trial is testing

Pilot Study to Assess Dimethyl Fumarate Related GI Symptom Mitigation

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Rocky Mountain MS Research Group, LLC 5
Large-scale testing (Phase 3)UnknownNCT06071949
What this trial is testing

Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis

Who this might be right for
PainPain SyndromePain, Chronic+10 more
Apurano Pharmaceuticals GmbH 558
Not applicableNo Longer AvailableNCT02807285
What this trial is testing

Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Genentech, Inc.
Early research (Phase 1)Study completedNCT01326715
What this trial is testing

Manganese-Enhanced Magnetic Resonance Imaging in Healthy Volunteers and People With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 17
Not applicableStudy completedNCT01953523
What this trial is testing

Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions

Who this might be right for
Neurodegenerative DiseasesOsteoarthritisErectile Dysfunction+3 more
Elliot Lander 3,000
Not applicableStudy completedNCT02463318
What this trial is testing

The Effect of Melatonin on Gene Expression and Activity of the Sirt1 and Its Target Genes Catalase and MnSOD in Multiple Sclerosis Patients and Healthy Subjects

Who this might be right for
Multiple SclerosisOxidative Stress
Tehran University of Medical Sciences 34
Not applicableLooking for participantsNCT06068582
What this trial is testing

Don't be Late! Postponing Cognitive Decline and Preventing Early Unemployment in People With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Amsterdam UMC, location VUmc 270
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07804004
What this trial is testing

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Refractory Neurologic Autoimmune Disease

Who this might be right for
Progressive Multiple Sclerosis (PMS)Neuromyelitis OpticaMyelin Oligodendrocyte Glycoprotein Antibody-associated Disease+2 more
CRISPR Therapeutics 220
Not applicableLooking for participantsNCT07653984
What this trial is testing

Cohort Study on Neuroimmune Diseases in the Reproductive Age

Who this might be right for
Neuromyelitis Optica Spectrum Disorders (NMOSD)Multiple SclerosisAutoimmune Encephalitis+3 more
Third Affiliated Hospital, Sun Yat-Sen University 100
Large-scale testing (Phase 3)Ended earlyNCT04944784
What this trial is testing

Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Cytokinetics 489
Not applicableUnknownNCT02960984
What this trial is testing

Neurorehabilitation on Upper Limb and on Fatigue in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Fondazione Don Carlo Gnocchi ETS 20
Post-approval studies (Phase 4)Looking for participantsNCT07614321
What this trial is testing

Silodosin for Urinary Symptoms in Female Patients With Multiple Sclerosis

Who this might be right for
Multiple SclerosisLower Urinary Track Symptoms
Atlantic Health System 60
Not applicableStudy completedNCT00262314
What this trial is testing

Prospective, Open-label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
EMD Serono 509
Not applicableStudy completedNCT05209815
What this trial is testing

Safety of Exposure to Natalizumab During Pregnancy

Who this might be right for
Multiple Sclerosis
University Hospital, Bordeaux 68
Not applicableLooking for participantsNCT06161376
What this trial is testing

Role of Urinary Sphingosine 1-Phosphate as a Biomarker for Detrusor Hyperactivity in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University Hospital, Toulouse 400
Not applicableUnknownNCT02481882
What this trial is testing

Baseline Cortical Haemodynamics in MS

Who this might be right for
Multiple Sclerosis
University of Nottingham 80
Not applicableStudy completedNCT02424825
What this trial is testing

Rouxbe Pilot for MS

Who this might be right for
Multiple Sclerosis
Oregon Health and Science University 15
Not applicableStudy completedNCT03636789
What this trial is testing

Evaluation of the Prevalence of Oculomotor Disorders in Patients With Radiologically Isolated Syndrome

Who this might be right for
Radiologically Isolated Syndrome (RIS)Multiple Sclerosis
Centre Hospitalier Universitaire de Nīmes 61
Testing effectiveness (Phase 2)WithdrawnNCT00986960
What this trial is testing

Effect of Adrenocorticotropin Injection With Weekly Interferon Beta in Patients With Relapsing Remitting Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
University at Buffalo
Not applicableStudy completedNCT01075880
What this trial is testing

Post-Authorization Observational Study to Evaluate Cognition and Fatigue in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Treated With Rebif®

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Merck KGaA, Darmstadt, Germany 300
Next Page